Microfluidic devices present unique advantages for the development of efficient drug carrier
particles, cell-free protein synthesis systems, and rapid techniques for direct drug screening …

Nanotechnology in medical applications, especially in oncology as drug delivery systems,
has recently shown promising results. However, although these advances have been …

The advent of nanomedicine marks an unparalleled opportunity to advance the treatment of
various diseases, including cancer. The unique properties of nanoparticles (NPs), such as …

The intrinsic limitations of conventional batch synthesis have hindered its applications in
both solving classical problems and exploiting new frontiers. Microfluidic technology offers a …

Cancer remains a leading cause of death worldwide with more than 10 million new cases
every year. Tumor-targeted nanomedicines have shown substantial improvements of the …

Loss of function in tumor suppressor genes is commonly associated with the
onset/progression of cancer and treatment resistance. The p53 tumor suppressor gene, a …

With the advent of technology, the role of nanomaterials in medicine has grown
exponentially in the last few decades. The main advantage of such materials has been …

Nucleic acids are a promising type of therapeutic for the treatment of a wide range of
conditions, including cancer, but they also pose many delivery challenges. For efficient and …

The microfluidic technique has brought unique opportunities toward the full control over the
production processes for drug delivery carriers, owing to the miniaturisation of the fluidic …